NeuroFront Therapeutics
PrivateCompany Overview
NeuroFront Therapeutics is a clinical-stage biotechnology company that develops and commercializes innovative neuroscience therapies to address unmet medical needs in China and Asia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnologyCNS disorderscentral nervous systemsmall molecule drugneuropathic painPDPNpainful diabetic peripheral neuropathyclinical-stage biotechnon-opioid pain managementdrug licensingbiopharmaclinical trialsADHDmigraine treatmentdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroFront Therapeutics Comparables
Compare NeuroFront Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| 上海赛默罗生物科技有限公司 | 83% | |
| Novaremed AG | 83% | |
| Ignis Therapeutics | 80% | |
NeuroFront Therapeutics Funding Rounds
Historical fundraising activity
NeuroFront Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about NeuroFront Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?